Introduction {#s1}
============

Ubiquitin (Ub) is a 76 amino acid, highly conserved protein among eukaryotes post-translationally modifying proteins thereby dictating almost every fundamental cellular process. Malfunction of its action drives diverse pathologies such as cancer and neurological disorders like Parkinson\'s, Alzheimer\'s, and Huntington\'s disease (McNaught et al., [@B56]; Du and Mei, [@B15]; Ciechanover and Kwon, [@B7]). It exerts its action through the covalent attachment of its C-terminus to the target substrates by an orchestrated enzymatic cascade composed by three different enzyme families named E1, E2, E3 (writers of the code) ([Figure 1A](#F1){ref-type="fig"}). This conjugation process, commonly referred to as ubiquitination, is initiated once the E1 activating enzyme catalyzes adenylation of the C-terminus of Ub at the expense of ATP thereby forming a high-energy E1-Ub thioester. Afterwards, the activated Ub is transferred by trans-thioesterification to the cysteine of the E2 conjugating enzyme which allows E3 ligase mediated Ub conjugation the substrate lysine residue through a stable peptide bond. Ub transfer to the substrate can be carried out by three different mechanisms depending on the nature of participating E3 ligase \[RING, HECT, and RING-in-between-RING (RBR)\] (Zheng and Shabek, [@B93]). Activated Ub can be transferred onto the catalytic cysteine of the HECT E3s via a transthioesterification reaction followed by conjugation to the lysine residue of the substrate. Alternatively, transfer of the E2-Ub thioester to the substrate lysine is accomplished by the contribution of a scaffolding RING E3 enzyme accommodating both the E2-Ub complex and the substrate. RBR E3s catalyze Ub conjugation by a concerted RING/HECT hybrid mechanism in which the RING1 domain recruits the E2-Ub complex, followed by thioester transfer of Ub to a cysteine in the RING2 domain (Spratt et al., [@B76]).

![Complexity of the ubiquitin CODE **(A)** General overview ubiquitination process. **(B)** Ubiquitin chain types.](fchem-07-00931-g0001){#F1}

Different ubiquitination patterns can be observed depending on the constitution of the lysine residues of the substrate, giving rise to mono-ubiquitination or multi mono-ubiquitination, respectively. Additionally, this enzymatic process can be repeated by utilizing the ε-amine functionality of any of the seven internal lysine residues or the N-terminal amine of Ub. Thus, self-conjugation of Ub to any of these residues permits the formation of eight different homogenous polymeric Ub chains (M1, K6/11/27/29/33/48/63). Due to the different disposition adopted by each of these Ub linkages, a wide variety of cellular signaling (Akutsu et al., [@B3]) events can be modulated all exerting different biological outcomes. For instance, Lys-48 and Lys-63 linked poly-Ub, the best characterized polymeric chains are mainly involved in proteasome mediated protein degradation and cell signaling respectively, whereas the cellular responses of the remaining linkages, known as atypical chains, remains undefined (Kulathu and Komander, [@B45]). Furthermore, complexity can be augmented through permutation of linkages, either through modification of different internal lysines (branched chains) or by repetition of different linkages within the chain (heterologous/mixed chains) thereby endowing the UbCODE with an extraordinary versatility and specificity (Nakasone et al., [@B60]; Stolz and Dikic, [@B78]; Haakonsen and Rape, [@B29]) ([Figure 1B](#F1){ref-type="fig"}).

To counterbalance ubiquitination and further sculpting the physiological effects or rescuing proteins destined for proteasomal degradation, dedicated proteases known as deubiquitinases (DUBs) not only remove mono-Ub from their substrates, but also alter Ub chain topology (editors of the code) (Leznicki and Kulathu, [@B48]). Alternatively, modulating the formation and processing of Ub chains can be achieved through their interaction with Ubiquitin Binding Domains (UBDs). These UBDs are endowed with a specific affinity toward Ub or Ub chains permitting the modulation of both chain elongation as well as governing the interaction of the Ub chains with the substrates (Dikic et al., [@B12]).

While Ubiquitin represents the minimum entity to express a code, the Ubiquitin CODE as coined by Komander and Rape, it is a highly complex, yet still elusive signaling system reliant on the interplay of its "writers," "editors," and "readers" (Komander and Rape, [@B44]). Nonetheless, intricacy arises when Ub, is further "PTMylated" by the classical modifications such as acetylation (Ohtake et al., [@B63]), phosphorylation (Herhaus and Dikic, [@B38]), or ribosylation (Vivelo et al., [@B85]), or even by some Ubiquitin-like proteins (UbL). Structurally and biochemically similar to Ub, UbLs are covalently attached to the lysine residues of their substrates through the sequential action of dedicated activating, conjugating, and ligating enzymes. Conjugation of UbLs to Ub and vice versa, results in hybrid chains, expanding the utility of the Ubiquitin CODE to enable an extensive crosstalk among the different UbL pathways and the UPS (Schmidt and Dikic, [@B72]; Schimmel et al., [@B71]; Geoffroy and Hay, [@B25]; Hjerpe et al., [@B40]) ([Figure 1B](#F1){ref-type="fig"}). However, the assembly, topology, architecture, as well as the encoded information of these Ub/UbLs hybrid chains remains cryptic warranting the development of suitable reagents to decipher this intricate CODE.

Given the breadth of this review, we will focus on evidence supporting the existence of these Hybrid Chains with ubiquitin-like modifiers mainly composed of Ub and the UbL proteins NEDD8, SUMO, and ISG15 as well as the future potential for this emerging field. Additionally, we will touch upon the crosstalk between the Ubiquitin and the Ubiquitin-like enzyme cascades that cooperate to form hybrid Ub/UbL chains.

Ubiquitin-Like Proteins and Hybrid Chain Formatio {#s2}
=================================================

Small Ubiquitin-Related Modifier (SUMO)
---------------------------------------

SUMOylation, which is involved in a large plethora of fundamental cellular processes, is catalyzed through the interplay of specific enzymes and counteracted by the action of SUMO specific isopeptidases (Pichler et al., [@B66]). The SUMO family is composed by three different members known as SUMO-1, -2, and -3, which, subsequent to the exposure of their C-terminal di-glycine signature, are conjugated onto specific lysines embedded within a SUMO consensus motif (ψ-Lys-X-Glu, with ψ encoding a hydrophobic residue of their substrates) (Geiss-Friedlander and Melchior, [@B24]). While the most predominant isoforms SUMO-2 and SUMO-3 are virtually identical and mainly form K11-linked polymeric chains (Matic et al., [@B53]; Hendriks et al., [@B34]), SUMO-1 bears only a 50% sequence similarity and does not form polymeric chains give the absence of the necessary conserved lysine residue within the consensus motif (Saitoh and Hinchey, [@B69]). However, it has been shown that SUMO-1 can be linked to the end of a poly-SUMO-2/-3 chain, effectively terminating chain growth (Matic et al., [@B53]). Formation of SUMO-2/-3 chains is elicited upon cellular stressors such as heat shock (Saitoh and Hinchey, [@B69]) and their recognition is mediated by SUMO interactive motifs (SIMs)- specific regions interacting with SUMO and SUMO polymers (Song et al., [@B75]).

### Hybrid SUMO-Ub Chains

In addition to modification with SUMO itself, several proteomic studies have identified that Ubiquitination at various lysines in SUMO-1--3 can occur (Danielsen et al., [@B9]; Wagner et al., [@B86]; Hendriks et al., [@B34]; Hendriks and Vertegaal, [@B37]). Interestingly, while SUMO-1 cannot be SUMOylated, it is Ubiquitinated at six lysine residues most likely inducing a different response than Ubiquitinated SUMO-2/3 (Hendriks and Vertegaal, [@B37]). Thus, given the sheer number of Ubiquitination sites in SUMO a plethora of hybrid chains combinations are possible.

Intriguingly, proteomics revealed not only the vast number of modification possibilities on the different SUMO isoforms, but also allowed to identify whether the modification occurs on SUMO or on the Ubiquitin lysines (Hendriks et al., [@B34], [@B35]), further increasing the complexity ([Figure 2A](#F2){ref-type="fig"}). The hybrid chains predominantly occur upon specific stressors (Hendriks et al., [@B34]) ([Figure 2A](#F2){ref-type="fig"}) and despite the advances in detection and elucidation of the branched architecture of SUMO-Ub hybrid chains, comprehending their cellular function is still in its infancy. Discerning their physiological roles is of utmost importance since the architecture of hybrid SUMO-Ub chains expands the potential for distinct signaling events by SUMO and Ub.

![Mechanism for the formation of hybrid chains. **(A)** StubLs containing tandem of SIMS recognize polySUMO2/3 chains and poly-ubiquitinate in a linkage specific manner the PolySUMO chains targeting them for enhanced proteasomal degradation (Aillet et al., [@B1]) or initiates signaling for DDR events through the RAP80/BRCA1 complex (Guzzo et al., [@B28]). The insert highlights ubiquitinitated SUMO1-3 (Hendriks and Vertegaal, [@B37]) and SUMOylated Ubiquitin identified by proteomics so far (Hendriks et al., [@B34]). **(B)** Canonical and atypical pathways (Leidecker et al., [@B47]) and dual activity of HUWE1 under stress conditions which lead to formation of hybrid chains which protect the UPS by via the formation of aggregates that are no longer processed by the proteasome (Maghames et al., [@B51]). The insert displays identified Ub-Nedd8 linkages (Leidecker et al., [@B47]). **(C)** Although the mechanism for the formation of ISG15 hybrid chains is still outstanding, data supporting the existence of Ub-ISG15 is available. First, K29 gets ISGylated, followed by K48 as the second ISG15 site (Fan et al., [@B21]).](fchem-07-00931-g0002){#F2}

### SUMO-Ub Chain Signaling

Hybrid chains can be recognized by a variety of receptors containing tandem SUMO-interacting motifs (SIMs) and UBDs. Moreover, to counterbalance or alter the effect of SUMOylation, subsequent ubiquitination of poly-SUMOylated proteins, catalyzed by SUMO-targeted Ubiquitin ligases (STUbls) can ensue. Upon recognition of the poly-SUMO signal through virtue of their SIMs, STUbls install a specific Ub-linkage onto the lysine of the SUMO-modification (Sriramachandran and Dohmen, [@B77]). Although, SUMO-Ub chains were primarily identified on proteins impending proteasomal degradation (Lallemand-Breitenbach et al., [@B46]; Tatham et al., [@B83]; Erker et al., [@B20]; McIntosh et al., [@B55]), roles in maintaining genome stability (Guzzo et al., [@B28]; Nie and Boddy, [@B61]) have been assigned more recently through the K63 poly-ubiquitination of poly-SUMO chains ([Figure 2A](#F2){ref-type="fig"}). Here RNF4, a STUbl, mediates poly-ubiquitination of SUMOylated proteins, thereby evoking the recruitment of RAP80 and its subsequent interaction with BRCA1 complex, to promote genomic stability (Guzzo et al., [@B28]). Another example involves Arkadia which ubiquitinates SUMOylated xeroderma pigmentosum C (XPC), a pivotal player in nucleotide excision repair, driving XPC to UV-damaged DNA sites (Poulsen et al., [@B67]).

DUBs such as USP11 can trim or reverse ubiquitination on hybrid SUMO-Ub chains to modulate the associated cellular responses (Hendriks et al., [@B36]). Thus, the amalgamation of ubiquitination and SUMOylation resembles an efficacious strategy to confer both specificity and increased affinity to the target proteins (Aillet et al., [@B1]; Guzzo et al., [@B28]).

Neural Precursor Cell Expressed, Developmentally Downregulated 8 (NEDD8)
------------------------------------------------------------------------

Akin to SUMOylation, Neddylation is accomplished by its own specific enzymes and is counterbalanced by a few dedicated proteases (Enchev et al., [@B19]). Given the similarities between Ubiquitin and Nedd8, it is unsurprising that both have the propensity to form hybrid chains. However, the formation of Ubiquitin-Nedd8 hybrid chains occurs predominantly in response to proteotoxic stress, perhaps as a mechanism to dampen cellular signaling in this context or to protect the UPS from proteotoxicity (Maghames et al., [@B51]; Santonico, [@B70]). Neddylation and the Nedd8 enzyme cascade have been demonstrated to be crucial to the development of neurological disorders (Dil Kuazi et al., [@B13]; Mori et al., [@B57]; Chen et al., [@B6]; Lu et al., [@B50]). Thus, given the protective role of Ubiquitin-Nedd8 hybrid chains against proteotoxic stress, these complex posttranslational modifications may play a pivotal role in the pathogenesis and progression of neurodegenerative diseases (Ross and Poirier, [@B68]; Gestwicki and Garza, [@B26]; Dantuma and Bott, [@B10]; Valastyan and Lindquist, [@B84]; Sweeney et al., [@B82]).

In an attempt to elucidate the architecture of the hybrid chains several hybrid linkages were determined by SILAC-based proteomics upon proteasomal inhibition (Leidecker et al., [@B47]) ([Figure 2B](#F2){ref-type="fig"}). Neddylation occurs via the interplay of enzymes relying on its own specificity and is referred to as the "Canonical" pathway. However, under stress conditions such as proteasome inhibition, oxidative stress, or heat shock Neddylation is mediated "atypically" by the Ubiquitin activating enzyme UBE1 instead (Hjerpe et al., [@B40],[@B41]; Leidecker et al., [@B47]). This tight synchronization of the Ubiquitin and Nedd8 systems to fine-tune the cellular response during proteotoxic stress has been observed not only for UBE1, but also for also for the E3 ligase HUWE1, a crucial component of the Protein Quality Control (PQC) pathway (Xirodimas et al., [@B91]; Sung et al., [@B79],[@B80]), which targets ribosomal proteins (RPs) and protects the UPS from stress-induced toxicity by ribosomal protein aggregation (Maghames et al., [@B51]) ([Figure 2B](#F2){ref-type="fig"}). Importantly, during the persistence of stress, the unconjugated Ub pool is rapidly depleted triggering Neddylation through the Ubiquitin pathway and targeting several substrates typically ubiquitinated (Leidecker et al., [@B47]) ([Figure 2B](#F2){ref-type="fig"}). Akin to the sophisticated regulatory system provided by DUBs, research underscores that Nedd8-Ub hybrid chains seem to be modulated in a similar fashion by DUBs subsequent to cellular stress (Leidecker et al., [@B47]; Singh et al., [@B74], [@B73]).

Interferon (IFN)-Stimulated Gene 15 (ISG15)
-------------------------------------------

Firstly identified upon IFN treatment on Ehrlich ascites tumor cells (Farrell et al., [@B22]), ISG15 had initially not been identified as an Ubiquitin-like protein, until cross-reactivity toward Ub antibodies suggested the existence of UbL proteins (Haas et al., [@B30]). Unlike all other UbLs, ISG15 is composed of two Ub like domains tethered by a "hinge" polypeptide sequence. Analogous to Ub, ISG15 can be conjugated onto the target substrates through the orchestrated interplay of its E1, E2, and E3 enzymes through its exposed C-terminal glycine (Perng and Lenschow, [@B65]). Given its increased activation upon interferon stimulation, conjugation of ISG15 to protein substrates plays a crucial role in the antiviral response and thereby constituting a key contributor to innate immunity (Harty et al., [@B32]; Durfee et al., [@B16]; Perng and Lenschow, [@B65]).

In contrast to Ub, SUMO and NEDD8 (Jones et al., [@B42]), ISG15 has not been reported to generate polymeric chains and does not seem to have specific ISG15-interacting motifs. Although some studies have suggested an antagonistic relationship of Ub and ISG15 in certain contexts such as during tumorigenesis (Liu et al., [@B49]; Desai et al., [@B11]; Kim et al., [@B43]; Malakhova and Zhang, [@B52]; Wood et al., [@B88]), evidence of a crosstalk between ISG15 and Ub conjugation pathways still remains perplexing. Unexpectedly, a proteomic study revealed that ISG15 was conjugated to Ub (Giannakopoulos et al., [@B27]), and further investigation by Zhang et al. corroborated the formation of hybrid ISG15-Ub chains (Fan et al., [@B21]) ([Figure 2C](#F2){ref-type="fig"}).

Little is known about the biological function of these hybrid Ub-ISG15 chains, but it has been established that they do not act as proteasomal degradation signals. Thus, ISG15 could potentially function as a chain termination moiety to rescue ubiquitylated proteins from degradation. However, given the fact that ISG15 is predominantly conjugated to Ub via K29, a plausible role of these hybrid chains could be modulation of K29-Ub mediated biological signaling (Kulathu and Komander, [@B45]). Moreover, this type of hybrid chains could trigger new signaling pathways exerting different biological outcomes, but the assignment of their biological role is a daunting task since no ISG15 interactive motifs have been identified and readers containing both UIM and ISG15 interacting motifs cannot be predicted.

Perspectives {#s3}
============

Considering the impact of ubiquitination on regulating a vast array of fundamental biological processes, with dysregulation of the dedicated enzymes giving rise to pathologies such as cancer and neurodegenerative diseases, understanding its function merited the development and innovation of respective tools. Advances in synthetic strategies for generating ubiquitin, constituted a qualitative leap forward in the development of a plethora of ubiquitin assay reagents and numerous activity-based probes (ABPs) enabling study of enzymes involved in the complex system of ubiquitination (El Oualid et al., [@B18]; Ekkebus et al., [@B17]; Hameed et al., [@B31]).

The modification of Ub by another UbL complicates the deciphering of the spatial and temporal order of events, as well as the underlying biological role of this modification, underscoring the urgent need for new next generation ABPs and assay reagents. The lack of a robust methodology to chemically access some UbL proteins has hampered the study on the biological role that hybrid chains display as well as the identification of their readers, writers, erasers, and interpreters. Generating such complex hybrid chains is a challenging feat as the E2/E3 enzymes generating these linkages *in vitro* remain unknown. So far, only (semi)-synthetic strategies for obtaining ubiquitinated Rub1, the yeast NEDD8 homolog (Singh et al., [@B73]) and SUMO-2-K63diUb hybrid chains (Bondalapati et al., [@B4]) have been reported. Only in the last decade, efforts to devise synthetic strategies for UbL proteins such as Nedd8 (Mulder et al., [@B58]), SUMO (Dobrota et al., [@B14]; Wucherpfennig et al., [@B89]; Mulder et al., [@B59]) and Ufm1 (Ogunkoya et al., [@B62]; Witting et al., [@B87]) have been undertaken. More recently, ISG15 synthesis has been accomplished as a modular synthesis of both domains and its subsequent ligation (Xin et al., [@B90]). These developments in the chemical synthesis of UbL proteins in combination with the advancements made in polyUb probes (Mulder et al., [@B58]; Flierman et al., [@B23]; Paudel et al., [@B64]) open a new avenue to UbL and hybrid Ub/UbL reagents allowing research on their respective enzymatic cascades, but also enabling in depth studies on their crosstalk with ubiquitin.

Mass spectrometry (MS) has become an invaluable tool in the quest for understanding cell signaling and in particular to study the UPS (Heap et al., [@B33]). This type of proteomics relies on the isolation and enrichment of the target proteins through affinity-based approaches (Mattern et al., [@B54]) such as affimers, antibodies targeting the di-Glycine signature, anti/mini/nanobodies, endogenous tags, biotin, and molecular entities based in the repetition of UBDs and SIMs capturing poly-Ub and SUMO chains, respectively (TUBES and SUBES) (Hjerpe et al., [@B39]; Da Silva-Ferrada et al., [@B8]) with a high affinity. However, many of these approaches cannot be undertaken in the study toward hybrid Ub-UbL biology since they are not endowed with specific affinity toward these linkages or due to the shared homology under Ub and UbL proteins as exemplified by the shared GG remnant after enzymatic digestion. To overcome these pitfalls, an UbiSite antibody approach (Akimov et al., [@B2]) which relies on LysC digestion has recently been described to allow differentiation among Ub and UbL proteins. The translation of the existing affinity technologies toward hybrid chains and UbL proteins would facilitate the understanding of the crosstalk among the different Ub-UbL proteins. For example, an elegant combination of SIMs and UBDs, a mixed TUBE/SUBE approach, could potentially enrich for substrates endowed with hybrid chains generated by STUbLs. Unsurprisingly due to the high similarity of Nedd8 and Ub, all known binding domains with affinity for Nedd8 display cross-reactivity with Ub. Recently, the first specific binding domain for Nedd8 was reported (Castagnoli et al., [@B5]) and thus a similar approach as the TUBES/SUBES could potentially be designed, "NEBES."

Furthermore, a proteomic approach called Ubi-clipping (Swatek et al., [@B81]) has shown the great percentage (10--20%) of which branched chains are present in polymeric forms of Ub. This method relies on an engineered version of an ISG15-specificenzyme that partially removes Ub from substrates and leave the characteristic diglycine signature on Ub while simultaneously allowing the identification of different branched architectures. The translation of such technology into the hybrid chains field would shed light on the different architectures that such chains exhibit. In addition to this innovation, the generation of specific antibodies toward the linkage of hybrid chains, in a similar fashion as the first Ub branched K11/K48 antibody (Yau et al., [@B92]) could be a feasible approach toward the generation a Hybrid Chain Tool Box.

Despite the recent advances made in developing innovative reagents on the Ubiquitin-field, there are still many conundrums to be resolved regarding the writers, editors and readers of this part of the Ub CODE. The origin of the identified Ub-SUMO linkages in which Ub is SUMOylated is still unclear, the possibility of a parallel mechanism such as the STUbL in which SUMO ligases target polyUb-chains and SUMOylate (UbTSLs) them might explain their existence. The enzymes catalyzing the formation of Ub-ISG15 hybrid chains are still unknown and efforts to identify them should be undertaken. Moreover, the formation of these hybrid chains confers an extra layer of complexity to the CODE that could be translated into terms of specificity and increased affinity that the "readers" display for them. Such readers must be endowed with "hybrid" recognition domains which could be screened by bioinformatic analysis as exemplified in the discovery of RAP80 (Nie and Boddy, [@B61]). It has been shown that hybrid chains are processed by the proteasome more efficiently compared with poly-Ub or poly-SUMO chains. This pronounced affinity could be derived from the improved recognition of either a proteasome subunit or of a shuttle protein containing the aforementioned "hybrid" recognition domains. For the Ub-Nedd8 and Ub-ISG15 hybrid chains, the field is less explored and hybrid chain recognition domains still need to be identified.

The fact that Ub and UbL proteins can generate this array of chains, conferring new architectures and topology to the chains and thereby triggering different signaling events, increases complexity of the already intricate Ubiquitin CODE. The current knowledge regarding hybrid-chain formation is based upon chain formation between Ub and UbL proteins. However, a recent report revealed that a small fraction of NEDD8 becomes modified by K0-SUMO (Hendriks et al., [@B35]). Although SUMOylation of NEDD8 is likely to be a very rare event, it does extend the knowledge regarding hybrid chain cross-talk and opens a new perspective to the intrinsic code (Hendriks et al., [@B34]). The creation of tailored tools specific toward these hybrid chains by adapting the methodology already applied for the study of the Ubiquitin Proteasome System will augment our knowledge about hybrid chains.
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